Top compounds associated with response to ASRGL1


Feature Type Standardized
Nominal ANOVA
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.025 0.7
mRNA Dasatinib FIMM pan-cancer AAC -0.065 0.7
mRNA Imatinib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.016 0.7
mRNA SL 0101-1 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA bendamustine CTRPv2 pan-cancer AAC -0.015 0.7
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.014 0.7
Download CSV